A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

por Larkin, J M G, Ferguson, T R, Pickering, L M, Edmonds, K, James, M G, Thomas, K, Banerji, U, Berns, B, de Boer, C, Gore, M E
Publicado 2010

High occurrence of transportation and logistics occupations among vascular dementia patients: an observational study

por van Loenhoud, A. C., de Boer, C., Wols, K., Pijnenburg, Y. A., Lemstra, A. W., Bouwman, F. H., Prins, N. D., Scheltens, P., Ossenkoppele, R., van der Flier, W. M.
Publicado 2019

Involving research participants in a pan-European research initiative: the EPAD participant panel experience

por Gregory, S., Bunnik, E. M., Callado, A. B., Carrie, I., De Boer, C., Duffus, J., Fauria, K., Forster, S., Gove, D., Knezevic, I., Laquidain, A., Pennetier, D., Saunders, S., Sparks, S., Rice, J., Ritchie, C. W., Milne, R.
Publicado 2020

A randomised, phase II study of intetumumab, an anti-α(v)-integrin mAb, alone and with dacarbazine in stage IV melanoma

por O'Day, S, Pavlick, A, Loquai, C, Lawson, D, Gutzmer, R, Richards, J, Schadendorf, D, Thompson, J A, Gonzalez, R, Trefzer, U, Mohr, P, Ottensmeier, C, Chao, D, Zhong, B, de Boer, C J, Uhlar, C, Marshall, D, Gore, M E, Lang, Z, Hait, W, Ho, P
Publicado 2011

OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection

por Liu, MK, Ferrari, G, Salazar, J, Keele, B, Tanner, RL, Hraber, P, Giorgi, E, Ganusov, VV, Learn, GH, Salazar, MG, Moore, SR, Digleria, K, Yu, Z, Rostron, T, DeBoer, C, Williams, A, Margaret, C, Kopycinski, J, Campion, SL, Bourne, VE, Brackenridge, S, Hahn, B, Cohen, M, Borrow, P, Weinhold, K, Perelson, A, Shaw, G, Korber, BT, Goonetilleke, N, McMichael, AJ
Publicado 2009